Unassociated Document


    Exhibit
      10.1

    


    VioQuest
      Pharmaceuticals, Inc.

    Summary
      of 2007 Management Bonus Plans

     

    
      	 	 	 	 
	
              Daniel
                Greenleaf (President & CEO)

            	 	
              Maximum
                Amount

            	 
	
              Completion
                of financing resulting in proceeds of a targeted amount.

            	 	
              $

            	
              40,000

            	 
	
              Listing
                of the Company’s Common Stock on a national securities
                exchange

            	 	 	
              50,000

            	 
	
              Achievement
                of clinical/regulatory milestones

            	 	 	
              65,000

            	 
	
              The
                acquisition of a compound as approved by the Board of
                Directors.

            	 	 	
              30,000

            	 
	
              Sale
                of Chiral Quest, Inc.

            	 	 	
              40,000

            	 
	
              Qualitative:
                Company Values: Candor, Boundarylessness, Speed of Action, Patient
                Centricity, Risk Taking, Accountability, People Development, Financial
                Discipline

            	 	 	
              
              

              25,000

            	 
	
              Total
                

            	 	
              $

            	
              250,000

            	 
	 	 	 	 	 
	 	 	 	 	 
	
              Edward
                Bradley, M.D. (Chief Scientific Officer)

            	 	
              Maximum
                Amount

            	 
	
              Achievement
                of pre-determined clinical/regulatory milestones

            	 	
              $

            	
              82,800

            	 
	
              Qualitative:
                Company Values: Candor, Boundarylessness, Speed of Action, Patient
                Centricity, Risk Taking, Accountability, People Development, Financial
                Discipline

            	 	 	
              9,200

            	 
	
              Total

            	 	
              $

            	
              92,000

            	 
	 	 	 	 	 
	 	 	 	 	 
	
              Brian
                Lenz (Chief Financial Officer)

            	 	
              Maximum
                Amount

            	 
	
              Completion
                of financing resulting in proceeds of a targeted amount.

            	 	
              $

            	
              11,100

            	 
	
              List
                Listing of the Company’s Common Stock on a national securities
                exchange

            	 	 	
              16,650

            	 
	
              Achievement
                of clinical/regulatory milestones

            	 	 	
              5,550

            	 
	
              Sale
                of Chiral Quest, Inc.

            	 	 	
              16,650

            	 
	
              Qualitative:
                Company Values: Candor, Boundarylessness, Speed of Action, Patient
                Centricity, Risk Taking, Accountability, People Development, Financial
                Discipline

            	 	 	
              
              

              5,550

            	 
	
              Total

            	 	
              $

            	
              55,500